Complix

Developer of protein based therapeutics using proprietary alpha-body technology

placeDiepenbeek, Flanders, Belgium calendar_todayFounded 2008 groups13 employees language complix.com

Registered entities

Innovation

16 patent families (7 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 592 times.

YearFilings
20125
20133
20144
20155
20165
20175
20182
20191
20201
20221
20232
20241

Investor mix

14 investors on record; lead investors include Vesalius Biocapital Partners, LRM, CRP Sante, Crédit Agricole Private Equity.

Investor typeCountShare
Venture capital321%
Private equity429%
Bank & private debt214%
Other / undisclosed536%
Coming soon